Dual-Language Brief Mindfulness-Oriented Recovery Enhancement (B-MORE) vs Brief Cognitive-Behavioral Therapy (B-CBT) for Chronic Pain
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Program Feasibility
研究概览
简要总结
This randomized controlled trial aims to test both English and Spanish versions of two, benign behavioral interventions for adults with chronic pain -- 1) Brief Mindfulness-Oriented Recovery Enhancement (B-MORE), and 2) Brief Cognitive- Behavioral Therapy (B-CBT).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Having a chronic pain condition
- •Average pain of > 3 in the last week
- •Willingness to engage with study assessments and interventions
- •Understanding English or Spanish instructions fluently
- •Age 18 and above.
排除标准
- •Unable to consent because of physical or mental incapacity
- •Have previous, formal mindfulness or CBT training (e.g., MBSR)
- •Have pain from a current cancer diagnosis
- •Unstable illness that may interfere with treatment
- •Had surgery within the previous three months
- •Had pain relieving injections, such as cortisone or hyaluronate, within the previous three months.
研究组 & 干预措施
Brief Behavioral Intervention #1
Brief Mindfulness Oriented Recovery Enhancement (B-MORE)
干预措施: Brief Mindfulness Oriented Recovery Enhancement (Behavioral)
Brief Behavioral Intervention #2
Brief Cognitive-Behavioral Therapy (B-CBT)
干预措施: Brief Cognitive-Behavioral Therapy (Behavioral)
结局指标
主要结局
Program Feasibility
时间窗: At the first treatment session [1 hour] and the final treatment session [1 hour]
Feasibility will be assessed by intervention adherence rates (percentage of treatment sessions completed).
Treatment Acceptability
时间窗: Upon completion of the final treatment session [1 hour]
Treatment acceptability will be assessed by an adaptation of the Theoretical Framework of Acceptability scale (TFA).
次要结局
- Pain Catastrophizing(Baseline and 2, 6, and 12-week post-treatment follow-ups)
- Wellbeing(Baseline and 2, 6, and 12-week post-treatment follow-ups)
- Chronic Pain Symptoms(Baseline and 2, 6, and 12-week post-treatment follow-ups)
- Depressive Symptoms(Baseline and 2, 6, and 12-week post-treatment follow-ups)
- Anxiety Symptoms(Baseline and 2, 6, and 12-week post-treatment follow-ups)
研究者
Adam Hanley
Assistant Professor
Florida State University